Greaves, W., Wan, H., Yee, K. L., Kandala, B., Vaddady, P., & Hwang, C. (2019). Doravirine Exposure and HIV-1 Suppression after Switching from an Efavirenz-Based Regimen to Doravirine-Lamivudine-Tenofovir Disoproxil Fumarate. Antimicrob Agents Chemother.
Chicago-стиль цитированияGreaves, Wayne, Hong Wan, Ka Lai Yee, Bhargava Kandala, Pavan Vaddady, and Carey Hwang. "Doravirine Exposure and HIV-1 Suppression After Switching From an Efavirenz-Based Regimen to Doravirine-Lamivudine-Tenofovir Disoproxil Fumarate." Antimicrob Agents Chemother 2019.
MLA-цитированиеGreaves, Wayne, et al. "Doravirine Exposure and HIV-1 Suppression After Switching From an Efavirenz-Based Regimen to Doravirine-Lamivudine-Tenofovir Disoproxil Fumarate." Antimicrob Agents Chemother 2019.